ERBB2 and cholangiocarcinoma: Gong et al. (2020) found EGR4 facilitated tumor cell growth with high expression in cholangiocarcinoma. Surprisingly, EGR4 was highly expressed and had a significantly negative association with ER+/PR+/HER2+ status.